Skip to main content

Security report for drughulp.be

drughulp · Healthcare · Belgium

Medium risk. 4 critical or high findings in GDPR outside view and SSL/TLS.

Security score

73/100

Risk levelMedium

0–100, higher is better. How it is calculated

Drughulp.be is a Belgian non-profit online platform dedicated to providing scientific information about drugs, self-tests, online self-help, and professional support for individuals dealing with drug use and addiction. The website serves a mature audience seeking reliable and anonymous help, offering resources such as drug information, self-assessment tests, and online guidance. It is part of a broader ecosystem of related health support websites under the same initiative. Technically, the site uses modern web technologies including jQuery, Matomo analytics, Google Fonts, and an accessibility widget, delivering a good user experience with mobile optimization and clear navigation. Security posture is solid with HTTPS enforced and no visible vulnerabilities, though security headers and explicit cookie consent mechanisms could be improved. WHOIS data is restricted due to registry policy, limiting domain ownership transparency but the website content and affiliations support its legitimacy. Overall, drughulp.be is a trustworthy and professional resource in the healthcare non-profit sector with room for minor security and privacy enhancements.

Scanned

NIS2 and GDPR posture

GDPR outside view
28/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching drughulp.be

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
85
Email security
85
DNS health
70
Network security
100
GDPR outside view
28
Average
73

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The website occupies a niche in the healthcare and non-profit sector focused on drug information and addiction support in Belgium. It benefits from a network of sister sites addressing related health issues, enhancing its market position and reach. The business model is service-oriented, providing free and anonymous support to users. Key competitive advantages include scientific content, anonymity, and integration of self-help and professional guidance. The platform targets individuals concerned about their drug use or that of loved ones, offering accessible and tailored support. Growth indicators include the presence of multiple related domains and active content updates. Partnerships with recognized health organizations and use of secure communication channels strengthen its credibility.

Security posture

The website demonstrates a mature security posture with mandatory HTTPS and secure chat features for personal help. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, the absence of security headers such as Content-Security-Policy and Strict-Transport-Security is a gap that should be addressed. There is no published security policy or incident response information, nor a vulnerability disclosure program, which limits transparency. Privacy compliance is good with a privacy policy present and GDPR considerations evident, but cookie consent mechanisms are lacking. Overall, the site is secure for users but could improve in formalizing security governance and enhancing technical controls.

Recommendations

  1. Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security to harden the site against common attacks.
  2. Add a clear cookie consent banner or mechanism to comply fully with privacy regulations and improve user transparency.
  3. Publish a security policy and incident response plan on the website to enhance trust and preparedness.
  4. Consider establishing a vulnerability disclosure policy or security.txt file to encourage responsible reporting of security issues.
  5. Regularly audit and update third-party scripts and libraries to mitigate risks from external dependencies.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
drughulp
Description
Website providing scientific information about drugs, self-tests, online self-help, and professional support for drug problems.
Key services
Drug information, Self-tests for drug use, Online self-help programs, Online professional guidance, Support forums
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Matomo Analytics, Google Fonts, UserWay Accessibility Widget
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • Secure chat for personal help
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Matomo
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Matomo
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content about drug information and support.
  2. No WAF or blocking detected.
  3. WHOIS data is restricted by registry policy, limiting domain ownership transparency.
  4. Site uses HTTPS with good SSL configuration.
  5. No explicit cookie consent mechanism found.
  6. Contact information is available via email obfuscation and contact form.
  7. No phone numbers or physical addresses explicitly found.
  8. Site uses Matomo analytics and UserWay accessibility widget.
  9. Content is targeted at mature audiences seeking drug-related help, no adult explicit content.
  10. Good navigation structure with multiple sections and clear menus.
Technical notes

Notes

The website uses a modern but straightforward technology stack including jQuery for DOM manipulation, Matomo for privacy-focused analytics, Google Fonts for typography, and UserWay for accessibility compliance. The site is mobile-optimized with responsive design and good navigation clarity. Performance is moderate, likely due to external resources and image assets. No CMS or hosting provider information was detected. The site lacks advanced frameworks but is well-structured and functional. Technical risks include missing security headers and lack of explicit cookie consent, which could impact compliance and security posture. Opportunities exist to modernize the stack with newer frameworks and improve performance and security controls.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with drughulp.be. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review drughulp.be.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.